Isabel Ibarra-Gonzalez
Overview
Explore the profile of Isabel Ibarra-Gonzalez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
414
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nambo-Venegas R, Enriquez-Carcamo V, Vela-Amieva M, Ibarra-Gonzalez I, Lopez-Castro L, Cabrera-Nieto S, et al.
Metabolomics
. 2025 Feb;
21(2):28.
PMID: 39979511
Objective: To develop and validate predictive models using machine learning and circulating metabolites for forecasting responses to neoadjuvant therapy among breast cancer patients, enhancing personalized treatment strategies. Methods: Based on...
2.
Vela-Amieva M, Alcantara-Ortigoza M, Gonzalez-Del Angel A, Fernandez-Hernandez L, Reyna-Fabian M, Estandia-Ortega B, et al.
Int J Mol Sci
. 2024 Nov;
25(21).
PMID: 39519275
Biochemical phenotyping has been the milestone for diagnosing and managing patients affected by inborn errors of intermediary metabolism (IEiM); however, identifying the genotype responsible for these monogenic disorders greatly contributes...
3.
Lopez-Mejia L, Vela-Amieva M, Guillen-Lopez S, Mancera-Hernandez D, Ibarra-Gonzalez I, Medina-Torres E, et al.
Nutrients
. 2024 Jun;
16(11).
PMID: 38892708
Propionate defects (PDs) mainly include methylmalonic (MMA) and propionic acidemia (PA) defects. Lifelong PD patients progress from the compensated to the decompensated stages, the latter of which are characterized by...
4.
Vela-Amieva M, Alcantara-Ortigoza M, Gonzalez-Del Angel A, Ibarra-Gonzalez I, Fernandez-Hernandez L, Guillen-Lopez S, et al.
Children (Basel)
. 2023 Dec;
10(12).
PMID: 38136067
Hyperphenylalaninemia (HPA), which includes phenylketonuria (PKU), is a genetic autosomal recessive disorder arising from a deficiency in the enzyme named phenylalanine hydroxylase (PAH). Affected patients can experience severe and irreversible...
5.
Ibarra-Gonzalez I, Fernandez-Lainez C, Vela-Amieva M, Guillen-Lopez S, Belmont-Martinez L, Lopez-Mejia L, et al.
Int J Neonatal Screen
. 2023 Oct;
9(4).
PMID: 37873850
Advances in an early diagnosis by expanded newborn screening (NBS) have been achieved mainly in developed countries, while populations of middle- and low-income countries have poor access, leading to disparities....
6.
Razo-Azamar M, Nambo-Venegas R, Meraz-Cruz N, Guevara-Cruz M, Ibarra-Gonzalez I, Vela-Amieva M, et al.
Diabetol Metab Syndr
. 2023 Jun;
15(1):116.
PMID: 37264408
Background: Gestational diabetes mellitus (GDM) represents the main metabolic alteration during pregnancy. The available methods for diagnosing GDM identify women when the disease is established, and pancreatic beta-cell insufficiency has...
7.
Lopez-Mejia L, Fernandez-Lainez C, Vela-Amieva M, Ibarra-Gonzalez I, Guillen-Lopez S
Nutrients
. 2023 Feb;
15(4).
PMID: 36839315
The relationship between protein and energy and their appropriate proportions in hyperphenylalaninemia (HPA) or phenylketonuria (PKU) patients in terms of growth have been poorly studied, especially in those diagnosed late....
8.
Martinez-Gomez L, Ibarra-Gonzalez I, Fernandez-Lainez C, Tusie T, Moreno-Macias H, Martinez-Armenta C, et al.
Front Immunol
. 2022 Nov;
13:936106.
PMID: 36341434
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection triggers inflammatory clinical stages that affect the outcome of patients with coronavirus disease 2019 (COVID-19). Disease severity may be associated with a metabolic...
9.
Palacios-Gonzalez B, Leon-Reyes G, Rivera-Paredez B, Ibarra-Gonzalez I, Vela-Amieva M, Flores Y, et al.
Nutrients
. 2022 Sep;
14(18).
PMID: 36145054
Metabolic syndrome (MetS) is a group of several metabolic conditions predisposing to chronic diseases. Individuals diagnosed with MetS are physiologically heterogeneous, with significant sex-specific differences. Therefore, we aimed to investigate...
10.
Alcantara-Ortigoza M, Hernandez-Ochoa B, Gonzalez-Del Angel A, Ibarra-Gonzalez I, Belmont-Martinez L, Gomez-Manzo S, et al.
Clin Biochem
. 2022 Sep;
109-110:64-73.
PMID: 36089067
Background: Newborn screening for glucose-6-phosphate dehydrogenase deficiency (G6PDd) was implemented in Mexico beginning in 2017. In a Mexican population, genotyping analysis of G6PD as a second-tier method identified a previously...